Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
This is an antibody preparation generated in rabbit by Dr. William North Professor of Physiology and Neurobiology of Dartmouth Medical School (now Geisel School of Medicine at Dartmouth College) using a synthetic peptide representing the last 18 C-terminal residues of the 39 amino acid glycopeptide, coupled to bovine thyroglobulin as antigen.
Specificity: No measureable reactivity with rat or mouse copeptin, no measureable reactivity with vasopressin or human vasopressin-related neurophysin.
Tested applications: IHC-formaldehyde-fixed tissues, Flow Cytometry, RIA, ELISA
Properties
Form: Liquid
Storage Instructions: Shipped at 4o C. Store at 4o C short term (1-2 weeks). Upon delivery aliquot and store at -20o C or -80o C. Avoid freeze/Thaw cycling.
Storage buffer: Preservative none. Stable if stored as 1:100 dilutions in PBS containing 1.25 mg/ml of BSA at -20o C. Constituents: Whole serum
Purity: Whole Antiserum
Research Areas: Neuroscience, Endocrinology, Neuropeptides, Hormones, Neuroendocrinology, Measurement of Oxytocin Release.
----------------------------------------------------------------------------------
Woomera Therapeutics Inc. guarantees use of BORIS Y in each of the tested applications:
The application information recommends certain starting dilutions; however, optimal dilutions/concentrations should be determined by the end user.
Application
IHC: 1/1000-1/2000 Use at an assay dependent concentration
RIA: 1/15,000-20,000, Sensitivity to 2 pg; sensitivity range, 2-320 pg; 50% displacement at 40 pg; <no measurable cross-reaction with AVP or VP-HNP.
Flow Cytometry: >1/1000
Western: >1/1000
References:
Friedmann, A.S., Malott, K.A., Memoli, V.A., Pai, S.I., Yu, X.-M., and North, W.G. Products of vasopressin gene expression in small-cell carcinoma of the lung. Br. J. Cancer 69:260-263, 1994.
North, W.G., Pai, S., Friedmann, A., Yu, X., Fay, M., and Memoli, V. Vasopressin gene related products are markers of human breast cancer. Breast Cancer Research and Treatment 34:229-235, 1995.
Copyright © 2025 Woomera Therapeutics - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.